NMPA Approval

Recombinant Human Interleukin-2 for Injection

Approval Number

国药准字S20063101

Company长春生物制品研究所有限责任公司

Registration Date

August 31, 2020

Previous Approval Numbers

国药准字S20063101

Drug Information

Generic Name

注射用重组人白介素-2

Dosage Form

冻干制剂

Strength

20万IU/支

Drug Type

生物制品

Registration Date

August 31, 2020

Company Information

Applicant Company

Company Name长春生物制品研究所有限责任公司

Company Address

长春市高新技术开发区创新路1616号

Manufacturing Company

Company Name长春生物制品研究所有限责任公司

Company Address

长春市高新技术开发区创新路1616号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.